Galectin-9 reflects the interferon signature and correlates with disease activity in systemic autoimmune diseases. Response to: 'Biomarkers: to be or not to be' by Yavuz and Rönnblom

Ann Rheum Dis. 2020 Jan;79(1):e9. doi: 10.1136/annrheumdis-2018-214651. Epub 2018 Dec 8.

Lucas L van den Hoogen^{1

2}, Eefje H M van der Heijden^{3

2}, Maarten R Hillen^{3

2}, Jorre S Mertens^{3

2

4}, Ruth D E Fritsch-Stork^{5

6}, Timothy R D J Radstake^{3

2}, Joel A G van Roon^{3

2}

¹ Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands [email protected].
² Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
³ Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
⁴ Department of Dermatology, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁵ 1st Medical Department, Hanusch Hospital, Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, Vienna, Austria.
⁶ Faculty of Medicine, Sigmund Freud Private University, Vienna, Austria.

No abstract available

Keywords: antiphospholipid syndrome; autoimmune diseases; dermatomyositis; sjøgren's syndrome; systemic lupus erythematosus.

Publication types